USP38 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.397600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.916200E-01
Normal-vs-Stage2
6.598400E-01
Normal-vs-Stage3
1.463840E-02
Normal-vs-Stage4
5.076000E-01
Stage1-vs-Stage2
5.282400E-01
Stage1-vs-Stage3
2.459800E-03
Stage1-vs-Stage4
4.584800E-01
Stage2-vs-Stage3
6.835600E-02
Stage2-vs-Stage4
7.287800E-02
Stage3-vs-Stage4
9.717800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.941000E-01
Normal-vs-AfricanAmerican
6.801600E-01
Normal-vs-Asian
6.486600E-01
Caucasian-vs-AfricanAmerican
2.038800E-01
Caucasian-vs-Asian
8.808200E-01
AfricanAmerican-vs-Asian
2.833400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.231400E-01
Normal-vs-Female
7.791800E-01
Male-vs-Female
6.777200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.976000E-01
Normal-vs-Age(41-60Yrs)
8.126000E-01
Normal-vs-Age(61-80Yrs)
5.461200E-01
Normal-vs-Age(81-100Yrs)
2.240000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.552800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.034800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.537600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.736200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.720100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.390200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.085800E-01
Normal-vs-Daily Drinker
2.125200E-01
Normal-vs-Weekly Drinker
4.161000E-01
Normal-vs-Occasional Drinker
9.775000E-01
Normal-vs-Social Drinker
8.574200E-01
Non Drinker-vs-Daily Drinker
5.788200E-01
Non Drinker-vs-Weekly Drinker
9.361400E-01
Non Drinker-vs-Occasional Drinker
7.931600E-02
Non Drinker-vs-Social Drinker
1.272440E-01
Daily Drinker-vs-Weekly Drinker
7.362400E-01
Daily Drinker-vs-Occasional Drinker
4.694000E-02
Daily Drinker-vs-Social Drinker
7.730000E-02
Weekly Drinker-vs-Occasional Drinker
1.824220E-01
Weekly Drinker-vs-Social Drinker
1.651640E-01
Occasional Drinker-vs-Social Drinker
7.603800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.423970E-01
Normal-vs-Grade 2
1.368500E-02
Normal-vs-Grade 3
1.520140E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.621400E-01
Grade 1-vs-Grade 3
9.644200E-01
Grade 1-vs-Grade 4
1.423970E-01
Grade 2-vs-Grade 3
6.359200E-01
Grade 2-vs-Grade 4
1.368500E-02
Grade 3-vs-Grade 4
1.520140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.715000E-01
Normal-vs-NonDiabetic
7.161400E-01
Diabetic-vs-NonDiabetic
3.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.765000E-01
Normal-vs-NoPancreatitis
6.899000E-01
Pancreatitis-vs-NoPancreatitis
8.535800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.700600E-01
Normal-vs-N1
6.759600E-01
N0-vs-N1
6.179800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.407200E-01
Normal-vs-TP53-NonMutant
9.512400E-01
TP53-Mutant-vs-TP53-NonMutant
4.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
